Detalhe da pesquisa
1.
Radiomics and machine learning analysis based on magnetic resonance imaging in the assessment of liver mucinous colorectal metastases.
Radiol Med
; 127(7): 763-772, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653011
2.
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
BMC Cancer
; 19(1): 899, 2019 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500586
3.
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Oncology
; 90(1): 36-42, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731722
4.
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
Int J Cancer
; 135(2): 379-90, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375277
5.
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
BMC Cancer
; 14: 875, 2014 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421252
6.
Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study.
Cancer Med
; 13(4): e6892, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457226
7.
Percutanous Electrochemotherapy (ECT) in Primary and Secondary Liver Malignancies: A Systematic Review.
Diagnostics (Basel)
; 13(2)2023 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36673019
8.
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
Front Oncol
; 13: 1084681, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814823
9.
Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics.
Infect Agent Cancer
; 18(1): 18, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927442
10.
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.
Cancers (Basel)
; 15(2)2023 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672301
11.
Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.
Eur J Nucl Med Mol Imaging
; 39(12): 1848-57, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053320
12.
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA Netw Open
; 4(7): e2118475, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309665
13.
Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
Cancers (Basel)
; 12(7)2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32708575
14.
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial.
Clin Colorectal Cancer
; 19(4): 270-276, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631788
15.
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol.
Ther Adv Med Oncol
; 12: 1758835920929589, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849914
16.
Precision medicine in gastric cancer.
World J Gastrointest Oncol
; 11(10): 804-829, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662821
17.
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.
J Nucl Med
; 60(11): 1560-1568, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30877175
18.
Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics.
Infect Agent Cancer
; 18(1): 28, 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147694
19.
Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.
Curr Cancer Drug Targets
; 18(5): 421-429, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183254
20.
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.
Front Pharmacol
; 9: 441, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773991